Impfstoff gegen Bordetella pertussis

European patent · EP0352250 · Deleted

Register entry

Publication number
EP0352250
Application number
EP89870113
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 20, 1989
Published
Jan 24, 1990
Granted
Sep 11, 1996
Deleted
Jul 19, 2009
Reason
Maximum term reached
IPC classes
C12N 15/31 (2006.01)
C12P 21/00 (2006.01)
A61K 39/10 (2006.01)
Priority
US 222991 22.07.1988
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 27, 2009

    Maximum term reached

    Published in Swissreg on 27.07.2009

  2. Jun 30, 2008

    Address changed

    Representative
    A. Braun, Braun, Héritier,, Eschmann AG, Patentanwälte, Holbeinstrasse 36-38, 4051 Basel → BOHEST AG, Postfach 160, 4003 Basel

    Published in +pat+ No 12 in 2008

  3. Nov 29, 1996

    Agent entered

    Representative
    A. Braun, Braun, Héritier,, Eschmann AG, Patentanwälte, Holbeinstrasse 36-38, 4051 Basel

    Published in PIDTJ No 22 in 1996

  4. Sep 13, 1996

    Granted

    Published in PIDTJ No 17 in 1996

Parties

Holder

SmithKline Beecham Biologicals S.A.

Rue de l'Institut 89, 1330 Rixensart, BE

Agent

BOHEST AG

Postfach 160, 4003 Basel

Inventor

Capiau, Carine

B-7092 Mons, BE

Locht, Camille

B-1320 Genval (Rixensart), BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.